EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Postbiotics as a Therapeutic Tool in Depression: Exploring into Molecular Pathways and Neuroprotective Effects

Sampriti Sarkar, Kousik Maparu, Khadga Raj Aran

Probiotics and Antimicrobial Proteins · 2026-03 · 18 (2) · 3241-3267

DOI: 10.1007/s12602-025-10703-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 13.08.2025. Verfasst von Sampriti Sarkar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, ISF College of Pharmacy, Moga, 142001, Punjab, India. Hauptthemen laut MEDLINE: Depression, Neuroprotective Agents, Probiotics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 169 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression, a debilitating mood disorder characterized by persistent sadness and anhedonia, affects millions worldwide, yet available therapies remain suboptimal and often cause undesirable side effects. Emerging evidence highlights the crucial role of gut microbiota in regulating mental health through the gut-brain axis, paving the way for novel therapeutic strategies. As per preclinical and clinical studies, there is a causal relationship between gut dysbiosis and depression via modulation of brain activity through the gut-brain axis (GBA), and the key to targeting microbes is key to treating depression. Postbiotics-bioactive compounds derived after fermentation have been shown to provide several health benefits, particularly in terms of neuroinflammation, neurotransmitter imbalance, mitochondrial dysfunction, and restoration of neuroplasticity associated with depression. This review explores the neuroprotective mechanisms by which postbiotics alleviate depression, including the modulation of neurotransmitter synthesis, suppression of neuroinflammation, mitigation of oxidative stress and mitochondrial dysfunction, and restoration of neuroplasticity. Furthermore, postbiotics hold potential as adjuvant therapy alongside conventional antidepressants, enhancing treatment efficacy and minimizing side effects. Despite promising initial findings, challenges such as standardized formulation, clinical dose optimization, and regulatory framework development must be addressed. Large-scale clinical trials are imperative to validate their therapeutic potential and facilitate integration into mainstream depression management. As research advances, postbiotics may redefine mental health treatment, emerging as a revolutionary microbiome-based approach for long-term patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionNeuroprotective AgentsProbioticsHumansGastrointestinal MicrobiomeAnimalsDysbiosis

Stichwörter der Autor:innen

DepressionGut-brain axisMental healthNeuroinflammationPostbiotics

Substanzen

Neuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacy Practice, ISF College of Pharmacy, Moga, 142001, Punjab, India.
  • Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga, 142001, Punjab, India.
  • Department of Pharmacy Practice, ISF College of Pharmacy, Moga, 142001, Punjab, India. bishalarann@gmail.com.
  • Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga, 142001, Punjab, India. bishalarann@gmail.com.

Zitieren

APA

Sarkar, S., Maparu, K., & Aran, K. R. (2026). Postbiotics as a Therapeutic Tool in Depression: Exploring into Molecular Pathways and Neuroprotective Effects. Probiotics and Antimicrobial Proteins, 18(2), 3241-3267. https://doi.org/10.1007/s12602-025-10703-2

Vancouver

Sarkar S, Maparu K, Aran KR. Postbiotics as a Therapeutic Tool in Depression: Exploring into Molecular Pathways and Neuroprotective Effects. Probiotics and Antimicrobial Proteins. 2026;18(2):3241-3267. doi:10.1007/s12602-025-10703-2

BibTeX
@article{Sarkar2026,
  author = {Sarkar, Sampriti and Maparu, Kousik and Aran, Khadga Raj},
  title = {Postbiotics as a Therapeutic Tool in Depression: Exploring into Molecular Pathways and Neuroprotective Effects},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {3241--3267},
  doi = {10.1007/s12602-025-10703-2}
}
Kostenlos starten →